MIM
ANIP icon

Macroview Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Macroview Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43
Closed -$2.57K – 105
2024
Q3 		$2.57K Hold
43
– – ﹤0.01% 452
2024
Q2 		$2.74K Hold
43
– – ﹤0.01% 455
2024
Q1 		$2.97K Hold
43
– – ﹤0.01% 480
2023
Q4 		$2.37K Sell
43
-149
-78% -$8.21K ﹤0.01% 504
2023
Q3 		$11.1K Sell
192
-7
-4% -$404 0.01% 224
2023
Q2 		$10.7K Buy
+199
New +$8.82K 0.02% 262

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Macroview Investment Management's ANIP Position: Q4 2024 in Review

Macroview Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2024, closing a stake of 43 shares — an estimated $2.57K sold.

Macroview Investment Management first reported a position in ANIP in Q2 2023 and held it in 6 quarters. The position peaked at $11.1K in Q3 2023. 205 funds tracked by Wall St. Rank hold ANIP as of Q4 2024.

  • Macroview Investment Management reported no remaining ANI Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 43 ANI Pharmaceuticals shares in Q4 2024, an estimated $2.57K.
  • Macroview Investment Management first reported a position in ANI Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Macroview Investment Management's ANI Pharmaceuticals position peaked at $11.1K in Q3 2023.
  • 205 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.